- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Mobia Medical';s stroke treatment included in AHA guidelines | 1 | Investing.com | ||
| Fr | Mobia Medical, Inc.: Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines | 1 | GlobeNewswire (USA) | ||
| 12.08. | Mobia Medical forecasts $54M-$56M 2026 revenue, citing 69%-75% growth target | 2 | Seeking Alpha | ||
| 11.08. | Mobia Medical meldet starkes Umsatzwachstum für Q2 2026, Aktie stagniert | 1 | Investing.com Deutsch | ||
| 11.08. | Mobia Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.08. | Mobia Medical, Inc.: Mobia Medical Reports Second Quarter 2026 Financial Results | 288 | GlobeNewswire (Europe) | AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments,... ► Artikel lesen | |
| 03.08. | Mobia Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| MOBIA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 21.07. | Mobia Medical, Inc.: Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026 | 1 | GlobeNewswire (USA) | ||
| 15.07. | Mobia Medical appoints Reza Zadno to board of directors | 1 | Investing.com | ||
| 15.07. | Mobia Medical beruft Medizintechnik-Veteranen Reza Zadno in den Verwaltungsrat | 3 | Investing.com Deutsch | ||
| 15.07. | Mobia Medical, Inc.: Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors | 156 | GlobeNewswire (Europe) | AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor... ► Artikel lesen | |
| 15.07. | Mobia Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.07. | Mobia Medical reports two-year stroke therapy data in Neurology | 1 | Investing.com | ||
| 14.07. | Mobia Medical, Inc.: Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim Paired VNS Therapy | 1 | GlobeNewswire (USA) | ||
| 02.07. | Mobia Medical: CMS schlägt stabilen Vergütungssatz für Vivistim-Verfahren vor | 1 | Investing.com Deutsch | ||
| 02.07. | Mobia Medical, Inc.: Mobia Medical Announces Vivistim Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule | 1 | GlobeNewswire (USA) | ||
| 04.06. | Mobia Medical, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 02.06. | Wolfe Research initiates Mobia Medical stock with outperform rating | 1 | Investing.com | ||
| 02.06. | BTIG initiates Mobia Medical stock coverage with buy rating | 1 | Investing.com | ||
| 02.06. | Goldman Sachs initiates Mobia Medical stock with buy rating on neuro tech | 2 | Investing.com |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,482 | -0,52 % | HEALWELL AI: HEALWELL AI's DARWEN AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation | Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN AI as a globally recognized... ► Artikel lesen | |
| LIFEWARD | 7,500 | +0,40 % | Lifeward Ltd.: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth | Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial... ► Artikel lesen | |
| IMUNON | 1,380 | 0,00 % | Imunon to host R&D day on Sept. 23 for ovarian cancer therapy | ||
| INSPIREMD | 0,780 | +5,41 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| MYOMO | 1,360 | -1,88 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| GT BIOPHARMA | 0,300 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2026 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3... ► Artikel lesen | |
| INOGEN | 4,660 | -0,85 % | Inogen (INGN) Cuts Guidance Even As Profitability Climbs | ||
| INTELLIGENT BIO SOLUTIONS | 2,330 | 0,00 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| GLUCOTRACK | 0,282 | 0,00 % | Glucotrack, Inc. Announces Reverse Stock Split | 1-for-15 reverse stock split to become effective as of the opening of trading on August 31, 2026
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack"... ► Artikel lesen | |
| LENSAR | 8,280 | -0,24 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 10,570 | +2,13 % | Lexaria Bioscience Corp.: DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2 | Proprietary DehydraTECH 3.0 amycretin tablet formulation more than doubled absolute bioavailability compared to a leading industry studyProprietary DehydraTECH 3.0 retatrutide tablet formulation increased... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,640 | 0,00 % | Incannex Healthcare: Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| MINIMED GROUP | 16,100 | -7,13 % | Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings | ||
| HEARTBEAM | 0,467 | 0,00 % | HeartBeam schließt Aktienverkaufsvereinbarung über 25 Millionen US-Dollar mit Titan Partners | ||
| JIN MEDICAL INTERNATIONAL | 2,360 | +0,85 % | JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results | CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen |
Das Unternehmen MOBIA MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 11,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOBIA MEDICAL INC finden Sie auf Wallstreet Online.